ライフサイエンスコーパス: calcitonin gene-related peptide

1 increased labelling of neuronal profiles for calcitonin gene related peptide.

2 ltaneous immunostaining for the neuropeptide calcitonin gene-related peptide.

3 sociated induction of c-Fos and depletion of calcitonin gene-related peptide.

4 9.5, growth associated protein 43, trkA, and calcitonin gene-related peptide.

5 nociceptive peptides such as substance P and calcitonin gene-related peptide.

6 C-fibers immunoreactive for substance P and calcitonin gene-related peptide.

7 sin I, SV2, or syntaxin and the neuropeptide calcitonin gene-related peptide.

8 ion of terminals within the VPMpc containing calcitonin gene-related peptide.

9 geted for anti-tyrosine hydroxylase and anti-calcitonin gene-related peptide.

10 matostatin, nefstatin-1, interleukin-11, and calcitonin gene-related peptide.

11 lar motoneurons, are also immunoreactive for calcitonin gene-related peptide.

12 Microiontophoresis of calcitonin gene-related peptide 8-37 also showed a signi

13 related peptide and the receptor antagonists calcitonin gene-related peptide 8-37 and olcegepant on t

14 Seventeen novel analogues of human calcitonin gene-related peptide(8-37) (hCGRP(8-37)) were

15 The expression of calcitonin gene-related peptide, a marker for peptidergi

16 Calcitonin gene-related peptide, adrenomedullin, amylin,

17 Deletion or silencing of calcitonin-gene-related peptide alpha (alphaCGRP) gene e

18 arch into the therapeutic potential of alpha-calcitonin gene-related peptide (alpha-CGRP) has been li

19 or 5 min) and by infusion for 5 min of alpha-calcitonin gene-related peptide (alpha-CGRP), which are

20 Calcitonin gene-related peptide-alpha (CGRPalpha), produ

21 s, increased hippocampal expression of alpha calcitonin gene-related peptide (alphaCGRP) transcripts,

22 Intravenous alpha-calcitonin gene-related peptide (alphaCGRP)(8-37) produc

23 onic levels of the inflammatory neuropeptide calcitonin-gene-related peptide, although inflammatory i

24 No puncta costain with calcitonin gene-related peptide and AMPA receptor subuni

25 ted, and lost immunodetectable expression of calcitonin gene-related peptide and capsaicin receptors,

26 d and thin myelinated afferents labeled with calcitonin gene-related peptide and isolectin B4, and in

27 Many colocalize with calcitonin gene-related peptide and isolectin B4, and th

28 ned practically all DRG cells that contained calcitonin gene-related peptide and neurokinins and thos

29 eptides that modulate LC function, including calcitonin gene-related peptide and pituitary adenylate

30 pression of mu opioid receptor and increased calcitonin gene-related peptide and substance P immunore

31 is an axon reflex, which may be mediated by calcitonin gene-related peptide and substance P released

32 peptidergic nociceptive fibers (positive for calcitonin gene-related peptide and substance P) and mye

33 n the adult spinal cord reduced sprouting of calcitonin gene-related peptide and substance P-containi

34 ther tested the effect of microiontophoresed calcitonin gene-related peptide and the receptor antagon

35 subset of sensory neurons that colabel with calcitonin gene-related peptide and TRPV1 suggestive of

36 and cOv are characterized with expression of calcitonin-gene-related peptide and cholecystokinin.

37 omatostatin, gastric inhibitory polypeptide, calcitonin gene-related peptide, and adrenomedullin.

38 apsaicin measured by (Ca(2+))(i), release of calcitonin gene-related peptide, and inward currents.

39 l peptidergic neuron markers substance P and calcitonin gene-related peptide, and the nonpeptidergic

40 A few calcitonin gene-related peptide- and substance P-positiv

41 aine, including sumatriptan, naproxen, and a calcitonin gene-related peptide antagonist.

42 staltic transmitters 5-hydroxytryptamine and calcitonin gene-related peptide; antagonists of these tr

43 assess the safety and efficacy of monoclonal calcitonin gene-related peptide antibodies for the preve

44 Variants of the calcitonin gene-related peptide artificially activate va

45 e fly homolog of the vertebrate neuropeptide calcitonin gene-related peptide, as a circadian wake-pro

46 modicum of investment, new targets, such as calcitonin gene-related peptide-based mechanisms, and en

47 ADA reduces blood levels of the neuropeptide calcitonin gene-related peptide but increases the neurop

48 AMP-dependent secretion of IL-1beta and beta-calcitonin gene-related peptide by dendritic cells.

49 ng protein 1 (RAMP1) comprise a receptor for calcitonin gene related peptide (CGRP) and intermedin.

50 ion induced by the Katp agonists cromakalim, calcitonin gene related peptide (CGRP) and the Kca agoni

51 mediating sensory neuropeptides galanin and calcitonin gene related peptide (CGRP) in a model of neu

52 The calcitonin gene related peptide (CGRP) pathway is import

53 distributions of the neuropeptides galanin, calcitonin gene related peptide (CGRP), substance P, and

54 (-IR) axons and a lateral portion containing calcitonin gene related peptide (CGRP)-IR neurons and fi

55 mouse bone induces a remarkable sprouting of calcitonin gene-related peptide (CGRP(+)) and neurofilam

56 ronal marker PGP9.5 and specific markers for calcitonin gene-related peptide (CGRP) (sensory C and A

57 Here, we report that calcitonin gene-related peptide (CGRP) activates CFTR-de

58 ing site of the homologous receptors for the calcitonin gene-related peptide (CGRP) and adrenomedulin

59 nables selective recognition of the peptides calcitonin gene-related peptide (CGRP) and adrenomedulli

60 ed receptors involved in energy homeostasis: calcitonin gene-related peptide (CGRP) and amylin recept

61 afferents with capsaicin, and antagonism of calcitonin gene-related peptide (CGRP) and neurokinin-1

62 asodilation that depends upon the release of calcitonin gene-related peptide (CGRP) and nitric oxide

63 s for the treatment of acute migraine target calcitonin gene-related peptide (CGRP) and serotonin (5-

64 and/or ARs lead to release of neuropeptides calcitonin gene-related peptide (CGRP) and substance P (

65 ed neurotrophic factor (GDNF); neuropeptides calcitonin gene-related peptide (CGRP) and substance P;

66 gic small-diameter primary afferent markers, calcitonin gene-related peptide (CGRP) and the lectin IB

67 expression of the potent vasoactive agents' calcitonin gene-related peptide (CGRP) and vascular endo

68 The peptide dilators calcitonin gene-related peptide (CGRP) and vasoactive in

69 of asymmetric axosomatic synapses containing calcitonin gene-related peptide (CGRP) and vGluT2.

70 However, the A11 does contain dopamine and calcitonin gene-related peptide (CGRP) and, by this comb

71 ntibody and double stained with chicken anti-calcitonin gene-related peptide (CGRP) antibody.

72 It has been proposed that substance P and calcitonin gene-related peptide (CGRP) are upregulated i

73 al studies have established the neuropeptide calcitonin gene-related peptide (CGRP) as a key player i

74 elevant and recent studies on the biology of calcitonin gene-related peptide (CGRP) as it pertains to

75 ntly suppressed basal neuronal expression of calcitonin gene-related peptide (CGRP) as well as stimul

76 Acetylcholine and calcitonin gene-related peptide (CGRP) cause vasodilatio

77 Calcitonin gene-related peptide (CGRP) co-internalizes w

78 Calcitonin gene-related peptide (CGRP) evokes anxiety-li

79 model to identify the changes that occur in calcitonin gene-related peptide (CGRP) expression in the

80 The calcitonin gene-related peptide (CGRP) family of G prote

81 evoked a concentration-dependent release of calcitonin gene-related peptide (CGRP) from cultured rat

82 reby inducing the release of substance P and calcitonin gene-related peptide (CGRP) from dorsal spina

83 CIM0216 elicited the release of the peptides calcitonin gene-related peptide (CGRP) from sensory nerv

84 The neuropeptide calcitonin gene-related peptide (CGRP) from the trigemin

85 Calcitonin gene-related peptide (CGRP) has been implicat

86 Calcitonin gene-related peptide (CGRP) has been implicat

87 The role of calcitonin gene-related peptide (CGRP) in cardiovascular

88 usion of neural factors, norepinephrine, and calcitonin gene-related peptide (CGRP) in denervated kid

89 sic science data support an integral role of calcitonin gene-related peptide (CGRP) in migraine patho

90 y of evidence supports an important role for calcitonin gene-related peptide (CGRP) in migraine patho

91 t, accumulating evidence supports a role for calcitonin gene-related peptide (CGRP) in the activation

92 rigins of gamma-aminobutyric acid (GABA) and calcitonin gene-related peptide (CGRP) in the efferent i

93 This study determined the role of calcitonin gene-related peptide (CGRP) in the maintenanc

94 Here, we show that neurons expressing calcitonin gene-related peptide (CGRP) in the parabrachi

95 ody of evidence points to a critical role of calcitonin gene-related peptide (CGRP) in the pathophysi

96 Neurons containing the neuropeptide calcitonin gene-related peptide (CGRP) increased in sens

97 In contrast with this, infusion of calcitonin gene-related peptide (CGRP) into BNST was rep

98 Calcitonin gene-related peptide (CGRP) is a 37-residue n

99 SIGNIFICANCE STATEMENT: The neuropeptide calcitonin gene-related peptide (CGRP) is a central play

100 Calcitonin gene-related peptide (CGRP) is a classic mole

101 The neuropeptide calcitonin gene-related peptide (CGRP) is a key player i

102 The neuropeptide calcitonin gene-related peptide (CGRP) is a key player i

103 Calcitonin gene-related peptide (CGRP) is a neuropeptide

104 Calcitonin gene-related peptide (CGRP) is a nonadrenergi

105 Calcitonin gene-related peptide (CGRP) is a potent arter

106 Calcitonin gene-related peptide (CGRP) is a potent neuro

107 Calcitonin gene-related peptide (CGRP) is a sensory neur

108 Calcitonin gene-related peptide (CGRP) is a validated ta

109 The neuropeptide calcitonin gene-related peptide (CGRP) is associated wit

110 Calcitonin gene-related peptide (CGRP) is crucial in the

111 Calcitonin gene-related peptide (CGRP) is involved in a

112 Calcitonin gene-related peptide (CGRP) is involved in th

113 The calcitonin gene-related peptide (CGRP) is released by mo

114 ed immunoabsorbent assay was used to measure calcitonin gene-related peptide (CGRP) levels in blood.

115 inase and estrogen receptor (CreER) into the calcitonin gene-related peptide (CGRP) locus that encode

116 very migraine patient.SIGNIFICANCE STATEMENT Calcitonin gene-related peptide (CGRP) monoclonal antibo

117 the contribution to cancer anorexia made by calcitonin gene-related peptide (CGRP) neurons in the pa

118 The calcitonin gene-related peptide (CGRP) pathway is a prom

119 The calcitonin gene-related peptide (CGRP) pathway is import

120 The neuropeptide calcitonin gene-related peptide (CGRP) plays a critical

121 Among these neuropeptides, calcitonin gene-related peptide (CGRP) plays a prominent

122 The mammalian calcitonin/calcitonin gene-related peptide (CGRP) pre-mRNA is alter

123 romote the nonneuronal pathway of calcitonin/calcitonin gene-related peptide (CGRP) pre-mRNA processi

124 of alternative processing of the calcitonin/calcitonin gene-related peptide (CGRP) pre-mRNA, the mec

125 Calcitonin gene-related peptide (CGRP) probably has a ro

126 We have examined the regulation of calcitonin gene-related peptide (CGRP) promoter activity

127 Calcitonin gene-related peptide (CGRP) receptor antagoni

128 Calcitonin gene-related peptide (CGRP) receptor antagoni

129 Calcitonin gene-related peptide (CGRP) receptor blockade

130 X: an ultrapotent analog of capsaicin) and a calcitonin gene-related peptide (CGRP) receptor blocker

131 The calcitonin gene-related peptide (CGRP) receptor is a het

132 fying proteins (RAMP) to become a functional calcitonin gene-related peptide (CGRP) receptor or an ad

133 A functional calcitonin gene-related peptide (CGRP) receptor requires

134 component of several receptors including the calcitonin gene-related peptide (CGRP) receptor.

135 ctivity modifying protein (RAMP) 1 to give a calcitonin gene-related peptide (CGRP) receptor.

136 olished by CGRP-(8-37), an antagonist of the calcitonin gene-related peptide (CGRP) receptor.

137 element (CRE), we tested the hypothesis that calcitonin gene-related peptide (CGRP) regulates the exp

138 unds abolished the enhanced capsaicin-evoked calcitonin gene-related peptide (CGRP) release and dynor

139 eover NO increased neuronal excitability and calcitonin gene-related peptide (CGRP) release and these

140 external jugular vein to determine levels of calcitonin gene-related peptide (CGRP) release before an

141 PA1-selective agonist, mustard oil (MO), for calcitonin gene-related peptide (CGRP) release from rat

142 idine (CLON) or their combination to inhibit calcitonin gene-related peptide (CGRP) release from spin

143 Capsaicin-evoked calcitonin gene-related peptide (CGRP) release was marke

144 rmacologic inhibition of substance P (SP) or calcitonin gene-related peptide (CGRP) signaling in Vglu

145 pharmacological inhibition of substance P or calcitonin gene-related peptide (CGRP) signaling in Vglu

146 had no effect on acanthosis; restoration of calcitonin gene-related peptide (CGRP) signaling reverse

147 DCN A and C fibers and their relationship to calcitonin gene-related peptide (CGRP) staining in the d

148 Calcitonin gene-related peptide (CGRP) stimulated CLR en

149 s depend, in part, on its ability to release calcitonin gene-related peptide (CGRP) through an uniden

150 Basal and capsaicin-evoked release of calcitonin gene-related peptide (CGRP) was measured in m

151 P 55,940 on depolarization-evoked release of calcitonin gene-related peptide (CGRP) were compared.

152 antibodies against VGLUT(1) , VGLUT(2) , and calcitonin gene-related peptide (CGRP) were used.

153 G-protein-coupled receptors (GPCR) and bind calcitonin gene-related peptide (CGRP) with similar affi

154 sal root ganglia (DRG), some neurons express calcitonin gene-related peptide (CGRP) without substance

155 - and large-sized neurons immunoreactive for calcitonin gene-related peptide (CGRP), a marker for pep

156 y trigeminal nerve fibers immunoreactive for calcitonin gene-related peptide (CGRP), a marker for pol

157 that reacted with a labeled antibody against calcitonin gene-related peptide (CGRP), a marker of noci

158 Calcitonin, calcitonin gene-related peptide (CGRP), adrenomedullin (

159 tor (CLR) for calcitonin (CT), amylin (Amy), calcitonin gene-related peptide (CGRP), and adrenomedull

160 ated with nerves containing the neuropeptide calcitonin gene-related peptide (CGRP), and CGRP inhibit

161 rves induced production of the neuropeptide, calcitonin gene-related peptide (CGRP), and CGRP treatme

162 Cholecystokinin (CCK), neuropeptide Y (NPY), calcitonin gene-related peptide (CGRP), and galanin all

163 ron somata, especially those also expressing calcitonin gene-related peptide (CGRP), and in central p

164 colocalization of EM2 with substance P (SP), calcitonin gene-related peptide (CGRP), and MOR in prima

165 ypes that express neurofilament (NF) 200 and calcitonin gene-related peptide (CGRP), and that these n

166 late cyclase-activating polypeptide (PACAP), calcitonin gene-related peptide (CGRP), and the neurotro

167 inotropic signaling by NO(-) was mediated by calcitonin gene-related peptide (CGRP), as treatment wit

168 The relative numbers of neurons containing calcitonin gene-related peptide (CGRP), cocaine- and amp

169 T), vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP), galanin (GAL), a

170 ed transcript (cart), cholecystokinin (cck), calcitonin gene-related peptide (cgrp), galanin, hypocre

171 ying small-diameter, "peptide-poor" neurons; calcitonin gene-related peptide (CGRP), identifying " pe

172 al root ganglion (DRG) neurones that express calcitonin gene-related peptide (CGRP), intracellular re

173 b, a humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP), is being investi

174 DRG) neurons with PAR2, substance P (SP) and calcitonin gene-related peptide (CGRP), mediators of pai

175 t the fusion of a RAMP1 co-receptor with the calcitonin gene-related peptide (CGRP), or calcitonin, t

176 reactive (IR) for neurofilament 200 (N52) or calcitonin gene-related peptide (CGRP), or labeled by is

177 The neuropeptides calcitonin gene-related peptide (CGRP), pituitary adenyl

178 g either isolectin B4 (IB4) or antibodies to calcitonin gene-related peptide (CGRP), respectively.

179 characterized by using six neuronal markers: calcitonin gene-related peptide (CGRP), substance P (SP)

180 ytochemical studies combined CTb with either calcitonin gene-related peptide (CGRP), substance P (SP)

181 clonal antibodies for class II beta-tubulin, calcitonin gene-related peptide (CGRP), substance P (SP)

182 Calcitonin gene-related peptide (CGRP), substance P (SP)

183 did not colocalize with the C-fiber markers calcitonin gene-related peptide (CGRP), substance P, and

184 Calcitonin gene-related peptide (CGRP), the most abundan

185 n exists between migraine and release of the calcitonin gene-related peptide (CGRP), the possibility

186 the PBel neurons that respond to CO2 express calcitonin gene-related peptide (CGRP), we hypothesized

187 ological states, we injected the vasodilator calcitonin gene-related peptide (CGRP), which induces he

188 lly no double staining was found for NR1 and calcitonin gene-related peptide (CGRP), which labels som

189 nerve fibers innervating taste buds contain calcitonin gene-related peptide (CGRP), which may be as

190 focuses on the topographical distribution of calcitonin gene-related peptide (CGRP)-containing cell b

191 We show that a subset of adult calcitonin gene-related peptide (CGRP)-expressing myente

192 In contrast, calcitonin gene-related peptide (CGRP)-expressing neuron

193 Previously, we identified calcitonin gene-related peptide (CGRP)-expressing neuron

194 afferent neurons are almost exclusively non-calcitonin gene-related peptide (CGRP)-immunoreactive (-

195 Some glomeruli of the OB contain calcitonin gene-related peptide (CGRP)-immunoreactive fi

196 Post-traumatic sprouting of calcitonin gene-related peptide (CGRP)-immunoreactive pr

197 ave shown previously that estrogen increases calcitonin gene-related peptide (CGRP)-immunoreactive se

198 ha-3 (GFRalpha3)-positive neurons (67%), and calcitonin gene-related peptide (CGRP)-positive neurons(

199 eads to robust regeneration and sprouting of calcitonin gene-related peptide (CGRP)-positive nocicept

200 ct contact with peripheral neurons secreting calcitonin gene-related peptide (CGRP).

201 ession of protein gene product (PGP) 9.5 and calcitonin gene-related peptide (CGRP).

202 ng protein 1 (RAMP1) comprise a receptor for calcitonin gene-related peptide (CGRP).

203 l pulp regulate capsaicin-induced release of calcitonin gene-related peptide (CGRP).

204 in-releasing peptide (GRP), substance P, and calcitonin gene-related peptide (CGRP).

205 ty for neuropeptide Y (NPY), calretinin, and calcitonin gene-related peptide (CGRP).

206 nd and binds to the same receptors as AM and calcitonin gene-related peptide (CGRP).

207 in Old MAs along with impaired dilatation to calcitonin gene-related peptide (CGRP).

208 ation and is accompanied by increased plasma calcitonin gene-related peptide (CGRP).

209 ophagus were removed, fixed, and stained for calcitonin gene-related peptide (CGRP).

210 of the membrane based on their expression of calcitonin gene-related peptide (CGRP).

211 and a population of cisplatin-activated lPBN calcitonin gene-related peptide (CGRP, a marker for glut

212 Gene expression of the neuropeptides calcitonin gene-related peptide (CGRP-alpha) and substan

213 hinly myelinated and unmyelinated fibers) or calcitonin gene-related peptide (CGRP; a marker more typ

214 ochemistry analysis using antibodies against calcitonin gene-related peptide (CGRP; sensory nerve fib

215 Benefits of calcitonin-gene related peptide (CGRP) inhibition have n

216 The neuroactive peptide calcitonin-gene related peptide (CGRP) is known to act a

217 the lateral parabrachial nucleus (lPBN) and calcitonin-gene related peptide (CGRP) projections from

218 des vasoactive intestinal polypeptide (VIP), calcitonin-gene related peptide (CGRP), substance P (SP)

219 amus (PVN; p<0.05) as well as an increase in calcitonin-gene related peptide (CGRP; p<0.05, one taile

220 knowledge, between the internal dynamics of calcitonin-gene-related peptide (CGRP) and amylin (islet

221 eurons immunoreactive to substance P (SP) or calcitonin-gene-related peptide (CGRP) or that bound the

222 f rat spinal sensory afferents identified by Calcitonin-Gene-Related-Peptide (CGRP) for peptidergic t

223 sh-fixed and stained for immunoreactivity to calcitonin-gene-related-peptide (CGRP).

224 y invested with peptidergic (substance P and calcitonin gene-related peptide [CGRP]) trigeminal polym

225 and splanchnic vasodilators (nitroglycerine, calcitonin gene-related peptide [CGRP], glucagon).

226 port the importance of the G-protein-coupled calcitonin gene-related peptide (CGRP1) receptor as a cr

227 adenylate cyclase-activating polypeptide and calcitonin gene-related peptide, down-regulates LC funct

228 circular muscle and release of serotonin and calcitonin gene-related peptide during the peristaltic r

229 istaltic reflex and release of serotonin and calcitonin gene-related peptide during the peristaltic r

230 born dopaminergic, GABAergic, nitrergic, and calcitonin gene-related peptide-expressing neurons and a

231 Here we identify calcitonin gene-related peptide-expressing neurons in th

232 42, a fully humanised monoclonal antibody to calcitonin gene-related peptide, for migraine prevention

233 een confirmed, and the subsequent release of calcitonin gene-related peptide from a mouse heart has b

234 capsaicin-induced release of substance P and calcitonin gene-related peptide from superfused segments

235 stimulatory role of Foxa2 at the calcitonin/calcitonin gene-related peptide gene enhancer was confir

236 s cell-specific expression of the calcitonin/calcitonin gene-related peptide gene.

237 onsible for other neurotransmitters, such as calcitonin gene-related peptide, histamine, and dopamine

238 minals inhibits exocytosis of immunoreactive calcitonin gene-related peptide (iCGRP) from peptidergic

239 f beta-adrenoceptors inhibits immunoreactive calcitonin gene-related peptide (iCGRP) release from cap

240 2 (PGE2; 1 microm)-stimulated immunoreactive calcitonin gene-related peptide (iCGRP) release or PGE2

241 apoptosis, and release of the immunoreactive calcitonin gene-related peptide (iCGRP).

242 on of rat mesenteric arteries in response to calcitonin gene-related peptide; (ii) rat paw edema in r

243 Calcitonin gene-related peptide immunolabeled (peptiderg

244 dult mice, MET was restricted to a subset of calcitonin gene-related peptide-immunoreactive (IR) myen

245 Calcitonin gene-related peptide-immunoreactive sensory i

246 ated release of the neuropeptide transmitter calcitonin gene-related peptide in mouse DRG neurons.

247 lease of the sensory mediators serotonin and calcitonin gene-related peptide in rat colon.

248 es in the skin and reduction of neuropeptide calcitonin gene-related peptide in the dorsal horn of sp

249 evention and provide support for the role of calcitonin gene-related peptide in the pathogenesis of m

250 vascular activation, including expression of calcitonin gene-related peptide in the trigeminal gangli

251 GFI1 colocalizes with chromogranin A and calcitonin-gene-related peptide in embryonic and adult m

252 As for sensory axons (immunostained for calcitonin gene-related peptide) in the urinary bladders

253 s involving CCSP and the NEB-specific marker calcitonin gene-related peptide indicate that BADJ-assoc

254 ng factor, thyrotropin-releasing hormone and calcitonin gene-related peptide) involved in the mediati

255 Substance P immunoreactive (-ir) and calcitonin gene related peptide-ir (CGRP-ir) were virtua

256 coexpressed with tyrosine hydroxylase-IR or calcitonin gene-related peptide-IR fibers.

257 PY, vesicular acetylcholine transporter, and calcitonin gene-related peptide-ir varicose fibers (5-20

258 ng proteins calbindin D-28k and parvalbumin, calcitonin gene-related peptide, iron, substance P, meth

259 y, accompanied by increased axonal growth of calcitonin gene-related peptide-labeled fibers in the do

260 cetylcholine, somatostatin, cholecystokinin, calcitonin gene-related peptide, leptin, and parietal ce

261 The potent vasodilator calcitonin gene-related peptide mediates neurogenic infl

262 d alter alternative splicing of a calcitonin/calcitonin gene-related peptide minigene in a hormone-de

263 E11.5, followed by neurofilament-M neurons, calcitonin gene-related peptide neurons (peak cell cycle

264 imary afferent (C fiber) origin, stained for calcitonin gene-related peptide or isolectin B4, but non

265 nt differences were observed in substance P, calcitonin gene-related peptide, or neuropeptide Y prote

266 ynapsin I, microtubule-associated protein-2, calcitonin gene-related peptide, or substance P.

267 ased the density of PGP9.5-positive, but not calcitonin gene-related peptide-positive, free nerve end

268 etrogradely labeled neurons from the DP were calcitonin-gene-related-peptide-positive (peptide-expres

269 Regenerated unmyelinated axons expressing calcitonin gene-related peptide project only to superfic

270 ibers were predominant (tyrosine hydroxylase/calcitonin gene-related peptide ratio 25.1 +/- 33.4; p <

271 ric synthesis of the major metabolite of the calcitonin gene-related peptide recepotor antagonist BMS

272 nputs and tested the effect of olcegepant, a calcitonin gene-related peptide receptor antagonist (1 m

273 While it has been demonstrated that calcitonin gene-related peptide receptor antagonists act

274 Calcitonin gene-related peptide receptor antagonists are

275 This is the first report on the efficacy of calcitonin gene-related peptide receptor antagonists at

276 pathway, showing that the central effects of calcitonin gene-related peptide receptor antagonists ext

277 uture non-vasoconstrictor approaches include calcitonin gene-related peptide receptor antagonists.

278 ore used to migraine, such as naproxen and a calcitonin gene-related peptide receptor inhibitor, olce

279 nucleus by specifically co-staining for the calcitonin gene-related peptide receptor subunits calcit

280 human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor, for the preven

281 e presence of the components of a functional calcitonin gene-related peptide receptor, the calcitonin

282 ain G-protein-coupled receptors, such as the calcitonin gene-related peptide receptor, to the plasma

283 while a CRLR heterodimer with RAMP1 yields a calcitonin gene-related peptide receptor.

284 ng to demonstrate the presence of functional calcitonin gene-related peptide receptors in the ventrop

285 hypothesis by measuring capsaicin-stimulated calcitonin gene-related peptide release (CGRP) as a meas

286 currents, calcium influx, and immunoreactive calcitonin gene-related peptide release from cultured TG

287 icin-evoked nocifensive responses, increased calcitonin gene-related peptide release from hindpaw ski

288 Calcitonin gene-related peptide release is suggested to

289 vation by icilin blocked capsaicin-triggered calcitonin-gene-related peptide release from colon tissu

290 Acute infection activates calcitonin gene-related peptide sensory neurons coupled

291 x by augmenting the release of serotonin and calcitonin gene-related peptide that mediate the sensory

292 ch, in return, allowed endoneurally released calcitonin gene-related peptide to pass through the nerv

293 sine hydroxylase [TH], dopamine transporter, calcitonin gene-related peptide, TrkC).

294 tions of met-enkephalin, vasotocin, galanin, calcitonin gene-related peptide, tyrosine hydroxylase, v

295 Calcitonin gene-related peptide, vesicular acetylcholine

296 e two potent vasodilators adrenomedullin and calcitonin gene-related peptide, we tested the effects o

297 istaltic reflex and release of serotonin and calcitonin gene-related peptide were also examined in ge

298 l dogs resulted in elevated plasma levels of calcitonin gene-related peptide, whereas neither the NO

299 y nerve terminals, triggering the release of calcitonin gene-related peptide which elicits vasorelaxa

300 axons (peripherin-positive axons containing calcitonin gene-related peptide), without changes in sym